NO20053490D0 - Methods for prediciting therapeutic response to agents acting on the growth hormone receptor - Google Patents
Methods for prediciting therapeutic response to agents acting on the growth hormone receptorInfo
- Publication number
- NO20053490D0 NO20053490D0 NO20053490A NO20053490A NO20053490D0 NO 20053490 D0 NO20053490 D0 NO 20053490D0 NO 20053490 A NO20053490 A NO 20053490A NO 20053490 A NO20053490 A NO 20053490A NO 20053490 D0 NO20053490 D0 NO 20053490D0
- Authority
- NO
- Norway
- Prior art keywords
- methods
- growth hormone
- hormone receptor
- therapeutic response
- agents acting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Diabetes (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pathology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Anesthesiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Child & Adolescent Psychology (AREA)
- Biomedical Technology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43486102P | 2002-12-19 | 2002-12-19 | |
| PCT/IB2003/005111 WO2004056864A1 (en) | 2002-12-19 | 2003-11-10 | Methods for predicting therapeutic response to agents acting on the growth hormone receptor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20053490D0 true NO20053490D0 (no) | 2005-07-18 |
| NO20053490L NO20053490L (no) | 2005-09-16 |
Family
ID=23725994
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20053490A NO20053490L (no) | 2002-12-19 | 2005-07-18 | Methods for prediciting therapeutic response to agents acting on the growth hormone receptor |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20040180358A1 (no) |
| EP (1) | EP1572738A1 (no) |
| JP (1) | JP2006525785A (no) |
| KR (1) | KR20050085855A (no) |
| CN (1) | CN1747968A (no) |
| AU (1) | AU2003278503A1 (no) |
| CA (1) | CA2510045A1 (no) |
| HR (1) | HRP20050563A2 (no) |
| NO (1) | NO20053490L (no) |
| RU (1) | RU2005122665A (no) |
| SE (1) | SE0300959D0 (no) |
| WO (1) | WO2004056864A1 (no) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1766067A1 (en) * | 2004-07-08 | 2007-03-28 | Pharmacia & Upjohn Company LLC | Methods for predicting therapeutic response to agents acting on the growth hormone receptor |
| GB0600122D0 (en) * | 2006-01-05 | 2006-02-15 | Univ Cardiff | Mutation in the growth hormone receptor |
| WO2008109357A1 (en) * | 2007-03-02 | 2008-09-12 | Mdrna, Inc. | Nucleic acid compounds for inhibiting apob gene expression and uses thereof |
| SG10201704777RA (en) * | 2009-06-08 | 2017-07-28 | Amunix Operating Inc | Growth hormone polypeptides and methods of making and using same |
| MX353186B (es) | 2009-09-03 | 2018-01-05 | Genentech Inc | Metodos para el tratamiento, diagnosis y monitoreo de artritis reumatoide. |
| US20150133383A1 (en) * | 2012-05-11 | 2015-05-14 | Prorec Bio Ab | Method for diagnosis and treatment of prolactin associated disorders |
| CN103014007A (zh) * | 2012-11-22 | 2013-04-03 | 新疆旺源驼奶实业有限公司 | 双峰驼α-乳白蛋白基因、重组蛋白及其克隆方法 |
| CN103014005A (zh) * | 2012-11-22 | 2013-04-03 | 新疆旺源驼奶实业有限公司 | 双峰驼a-fabp蛋白基因、重组蛋白及其克隆方法 |
| CN103014008A (zh) * | 2012-11-22 | 2013-04-03 | 新疆旺源驼奶实业有限公司 | 双峰驼ghr蛋白基因、重组蛋白及其克隆方法 |
| CN112322657B (zh) * | 2020-11-12 | 2023-04-25 | 浙江新码生物医药有限公司 | 一种人生长激素的体外活性检测方法 |
| CA3222510A1 (en) | 2021-06-18 | 2022-12-22 | Peptidream Inc. | Ghr-binding pending peptide and composition comprising same |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5210017A (en) * | 1990-11-19 | 1993-05-11 | Genentech, Inc. | Ligand-mediated immunofunctional hormone binding protein assay method |
| US5824642A (en) * | 1994-04-07 | 1998-10-20 | Genentech, Inc. | Treatment of partial growth hormone insensitivity syndrome |
| AU723494B2 (en) * | 1996-02-13 | 2000-08-31 | Jcr Pharmaceuticals Co., Ltd. | Mutant human growth hormones and their uses |
| US6080911A (en) * | 1997-04-15 | 2000-06-27 | Ohio University | Mice models of growth hormone insensitivity |
-
2003
- 2003-04-02 SE SE0300959A patent/SE0300959D0/xx unknown
- 2003-11-06 US US10/703,033 patent/US20040180358A1/en not_active Abandoned
- 2003-11-10 WO PCT/IB2003/005111 patent/WO2004056864A1/en active Application Filing
- 2003-11-10 EP EP03769803A patent/EP1572738A1/en not_active Withdrawn
- 2003-11-10 CA CA002510045A patent/CA2510045A1/en not_active Abandoned
- 2003-11-10 KR KR1020057011662A patent/KR20050085855A/ko not_active Application Discontinuation
- 2003-11-10 AU AU2003278503A patent/AU2003278503A1/en not_active Abandoned
- 2003-11-10 CN CNA2003801097023A patent/CN1747968A/zh active Pending
- 2003-11-10 RU RU2005122665/13A patent/RU2005122665A/ru not_active Application Discontinuation
- 2003-11-10 JP JP2004561735A patent/JP2006525785A/ja active Pending
-
2005
- 2005-06-16 HR HR20050563A patent/HRP20050563A2/hr not_active Application Discontinuation
- 2005-07-18 NO NO20053490A patent/NO20053490L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20050563A2 (en) | 2005-12-31 |
| AU2003278503A1 (en) | 2004-07-14 |
| NO20053490L (no) | 2005-09-16 |
| KR20050085855A (ko) | 2005-08-29 |
| CN1747968A (zh) | 2006-03-15 |
| JP2006525785A (ja) | 2006-11-16 |
| WO2004056864A1 (en) | 2004-07-08 |
| CA2510045A1 (en) | 2004-07-08 |
| SE0300959D0 (sv) | 2003-04-02 |
| EP1572738A1 (en) | 2005-09-14 |
| RU2005122665A (ru) | 2006-01-20 |
| US20040180358A1 (en) | 2004-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20053490D0 (no) | Methods for prediciting therapeutic response to agents acting on the growth hormone receptor | |
| LU92684I2 (fr) | Fidaxomicine ou son sel pharmaceutiquement acceptable | |
| DK1537078T3 (da) | Indoler med anti-diabetisk aktivitet | |
| ATE557036T1 (de) | Ox40 rezeptor bindende agenzien | |
| DK1862458T3 (da) | Terapeutiske midler anvendelige til smertebehandling | |
| ATE384053T1 (de) | Triazolderivate als tachykininrezeptor- antagonisten | |
| NO20034483L (no) | Tilkoblingsanordning for omradenett | |
| DE602004021250D1 (de) | 2-alkinyl- und 2-alkenyl-pyrazolo-ä4,3-eü -1,2,4-triazolo-ä1,5-cü -pyrimidinadenosin a2a rezeptorantagonisten | |
| DE50305924D1 (de) | Schichtsystem | |
| NO20051519D0 (no) | Stottemekanisme for hevarmhandtak | |
| DE60332134D1 (de) | Gerät zwecks hämodynamischbasierter optimierung der kardialen stimulation | |
| NO20043366L (no) | Kortikotropinfrigjorende faktor-2 reseptoragonister | |
| NO20044188L (no) | Kontrollerte frigjoringsdoseformer | |
| IL180098A0 (en) | Methods for predicting therapeutic pesponse to agents acting on the growth hormone receptor | |
| FI20020392A0 (fi) | Järjestely urinaalia varten | |
| ITPD20020251A1 (it) | Dispositivo per l'ottimizzazione dell'innesto di | |
| ITTO20050625A1 (it) | Impianto di alimentazione dell'acqua di raffreddamento. | |
| DK1495030T3 (da) | Ikke-steroidale progesteronreceptormodulatorer | |
| DE50313605D1 (de) | Versorgungsleitungsstruktur | |
| NO20022892L (no) | Forankringssystem | |
| ITUD20020252A1 (it) | Dispositivo di sostegno per l'ancoraggio di pannelli | |
| FI20020799A0 (fi) | Voimalaite | |
| NO20044364L (no) | Hydroksykarbamimidoyl-2-hydroksy-benzensulfonamidderivat-krystaller | |
| ITMI20020468A0 (it) | Dispositivo per la realizzazione di tetti | |
| FI5620U1 (fi) | Kiinnityslaite laitapalkkeja varten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |